Gene · 3428
Papers2,876
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,876
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention. | Drug Dev Res | 2025 | 41183131 | PubTator, text mining | PubMed |
| PRRs-Dependent and Independent Mechanisms of STING Signaling in Inflammatory and Autoimmune Diseases. | Biomedicines | 2025 | 41153813 | PubTator, text mining | PubMed |
| Deciphering lactate/lactylation networks in AML: integrated scRNA-seq and transcriptomics reveal functions and prognostic model. | BMC Cancer | 2025 | 41139200 | PubTator, text mining | PubMed |
| Mutation of the nuclear localization signals of the major tegument protein pp65 leads to impairment of human cytomegalovirus progeny production. | J Gen Virol | 2025 | 41118246 | PubTator, text mining | PubMed |
| Identification and Validation of Pyroptosis-Associated Gene Signature in Primary Sjögren's Syndrome. | Mediators Inflamm | 2025 | 41078717 | PubTator, text mining | PubMed |
| Deciphering the lactylation landscape in glioma: a novel gene signature predicts patient survival and immunotherapy sensitivity. | Front Immunol | 2025 | 41035644 | PubTator, text mining | PubMed |
| IFI16 Enhances Chemosensitivity of Breast Cancer Cells by Inhibiting DNA Damage Response. | Biomol Ther (Seoul) | 2025 | 41033779 | PubTator, text mining | PubMed |
| AIM2 and IFI16 as nucleic acid sensors in Periodontitis-Driven systemic inflammation: emerging evidence and therapeutic implications. | Clin Oral Investig | 2025 | 41028172 | PubTator, text mining | PubMed |
| Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity. | Clin Transl Med | 2025 | 41017066 | PubTator, text mining | PubMed |
| Emerging Research on Gene Delivery to the Nucleus via DNA Origami. | JACS Au | 2025 | 41001623 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| Advances and Deep Insights Into Lactylation: Essential Roles in Cellular Regulation and Disease Association. | J Cell Mol Med | 2025 | 40984037 | PubTator, text mining | PubMed |
| NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease. | Front Immunol | 2025 | 40959087 | PubTator, text mining | PubMed |
| Innate immune sensing and signaling: Co-opted for genome surveillance? Implications for tumorigenesis. | DNA Repair (Amst) | 2025 | 40934750 | PubTator, text mining | PubMed |
| Scvi-hub: an actionable repository for model-driven single-cell analysis. | Nat Methods | 2025 | 40921843 | PubTator, text mining | PubMed |
| RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology. | Stat Med | 2025 | 40911434 | PubTator, text mining | PubMed |
| HIV-2 evades restriction by ZAP through adaptations in the U3 LTR region despite increased CpG levels. | Nucleic Acids Res | 2025 | 40884399 | PubTator, text mining | PubMed |
Whole genome transcriptional analysis of intestinal biopsies and blood cells indicate genes involved in antioxidant defense systems, amino acid metabolism and antigen presentation in the pathogenesis of celiac disease. | BMC Med | 2025 | 40883722 | PubTator, text mining | PubMed |
| Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS/STING signaling in gastric cancer cells. | Cell Death Dis | 2025 | 40858547 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screening identifies SUV39H2 as a key regulator of oHSV-1 resistance in oral squamous cell carcinoma. | Cell Death Discov | 2025 | 40849299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3428/papers?page=5